PROJECT SAGE OLDCO, INC.
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $21.4M | $18.3M | $16.9M | $17.6M | $68.1M | $36.5M |
| Operating income | −$69.0M | −$46.4M | −$70.3M | −$103.6M | −$79.8M | −$62.9M |
| Net income | −$18.0M | −$54.7M | −$28.6M | −$26.5M | −$82.6M | −$64.0M |
| Total assets | $165.4M | $199.9M | $169.0M | $204.4M | $168.4M | $92.2M |
| Total liabilities | $165.8M | $159.0M | $169.5M | $122.5M | $101.5M | $64.6M |
| Equity | −$409,000 | $40.9M | −$557,000 | $81.9M | $66.9M | $27.6M |
| EPS (diluted) | $-2.89 | $-10.07 | $-17.91 | — | — | — |
| Shares out. | 62.4M | 57.3M | 50.0M | 29.2M | 19.6M | 18.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −322.7%
- Net margin
- −84.3%
- Return on equity
- 4411.0%
- Return on assets
- −10.9%
- Return on capital (ROCE)
- −92.0%
- Liabilities / assets
- 100.2%
- Debt / equity
- —
- Book value / share
- $-0.01
- Revenue growth (YoY)
- 16.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -15.81distress
- Accruals / assets
- 10.2%high accruals
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- High accruals — earnings-quality risk
- Strong return on equity (>15%)
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 29, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Menezes RonaldOfficer — President and CEO | Nov 13, 2023 | Tax withholding | 3,625 | $0.71 |
| Van Hove Caroline F.Director | Nov 13, 2023 | Tax withholding | 741 | $0.71 |
| Bennett Oliver ChristianOfficer — GC & Chief Compliance Officer | Sep 7, 2023 | Grant | 2,739 | $1.75 |
| Schmidt Andrew COfficer — Chief Financial Officer | Aug 3, 2023 | Tax withholding | 561 | $3.86 |
| Schaison PhilippeDirector | Jun 15, 2023 | Grant | 12,000 | $0.00 |
| Fisher MaryDirector | Jun 15, 2023 | Grant | 12,000 | $0.00 |
| Erenburg IrinaDirector | Jun 15, 2023 | Grant | 12,000 | $0.00 |
| Ebersole NoriDirector | Jun 15, 2023 | Grant | 12,000 | $0.00 |
| Casdin Alexander W.Director | Jun 15, 2023 | Grant | 15,000 | $0.00 |
| Schmidt Andrew COfficer — Chief Financial Officer | Mar 22, 2023 | Tax withholding | 2,718 | $1.38 |
| Menezes RonaldOfficer — President and CEO | Mar 22, 2023 | Tax withholding | 1,725 | $1.38 |
| Bennett Oliver ChristianOfficer — GC & Chief Compliance Officer | Mar 22, 2023 | Tax withholding | 2,070 | $1.38 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Modified shareholder rights · Director / officer changeJun 25, 2024
- Entered a material agreement · Completed an acquisition or disposition · Other material eventApr 29, 2024
- Entered a material agreement · Bankruptcy or receivership · New financial obligation · Delisting / listing-standard notice · Other material eventFeb 16, 2024
- Bankruptcy or receivership · Debt acceleration / triggering event · Regulation FD disclosure · Other material eventFeb 13, 2024
- Entered a material agreementJan 29, 2024
- Entered a material agreementJan 16, 2024
- Delisting / listing-standard noticeDec 20, 2023
- Results of operationsNov 9, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12GFORM 15-12GJun 25, 2024
- 8-KCURRENT REPORTJun 25, 2024
- 8-KApr 29, 2024
- 8-KApr 18, 2024
- 25-NSEApr 9, 2024
- NT 10-KMar 29, 2024
- SC 13G/AFeb 20, 2024
- 8-KCURRENT REPORTFeb 16, 2024
- 8-KCURRENT REPORTFeb 13, 2024
- SC 13GFeb 6, 2024
- 8-KCURRENT REPORTJan 29, 2024
- 8-KCURRENT REPORTJan 16, 2024
- 8-KCURRENT REPORTDec 20, 2023
- 4Nov 14, 2023
- 4Nov 14, 2023